“…However, some atypical antipsychotics have been linked to potentially serious metabolic adverse effects, including weight gain, type 2 diabetes mellitus, hyperglycemia, and diabetic ketoacidosis (4)(5)(6)(7)(8)(9). Most case reports of diabetes and diabetic ketoacidosis involve clozapine and olanzapine (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29), whereas a smaller number involve risperidone and quetiapine (17,(30)(31)(32)(33)(34)(35). To date, no reports have involved ziprasidone or aripiprazole, but patient exposure to these drugs is limited (36).…”